ClinicalTrials.govpublic full text
The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms
glucagon-like peptide-1 receptor agonists, type 2 diabetes, coronary arterial disease (cad), coronary arterial disease, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 830320
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.